Metaglip 2.5 mg / 500 mg Oral Tablet
RxNorm 861738
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 861738 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Metaglip 2.5 mg / 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Glipizide 2.5 mg / metformin hydrochloride 500 mg Oral Tablet [Metaglip]
(Atom ID: 12358653)
TMSY
Tall Man Lettering Synonym (TMSY):
GlipiZIDE 2.5 mg / metFORMIN hydrochloride 500 mg Oral Tablet [Metaglip]
(Atom ID: 5082311)
PSN
Prescribable Name (PSN):
Metaglip 2.5 mg / 500 mg Oral Tablet
(Atom ID: 6371657)
SY
Synonym (SY):
Metaglip 2.5 mg/500 mg (glipizide / metformin HCl) Oral Tablet
(Atom ID: 3265083)
TMSY
Tall Man Lettering Synonym (TMSY):
Metaglip 2.5 mg/500 mg (glipiZIDE / metFORMIN HCl) Oral Tablet
(Atom ID: 3742758)
SY